Leading the revolution in vaccine technology

Renowned scientists and entrepreneurs unite to create a unique platform for rapid development of highly versatile and efficient vaccines.

Covid-19 Vaccine Laboratory

About us

LinKinVax is a French biotechnology startup that focuses on speeding up vaccine development by bringing together basic science and industrial processes.


The discovery of dendritic cells’ role in adaptative immunity system lead to a Nobel Prize in 2011.
Ten years of research later, 3 vaccines are entering clinical trial in 2021-2022. 

Press releases

May 4, 2022

LinKinVax appoints Dr Jiong Ma as independent board member 

LinKinVax's Logo
March 15, 2022

LinKinVax announces a collaboration with GTP Bioways for the development and production of its second-generation vaccine against SARS-CoV-2

Interested in our project?